Key facts
- It has raised $1.5M.
- Notable investors include Plug and Play Tech Center, BioIndustry Association.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for IntelligenceQ
- ·The full record, as it builds
Funding rounds
No funding rounds for IntelligenceQ are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IntelligenceQ
Developer of AI Infrastructure designed for drug manufacturing processes. The company's platform optimizes processes, product quality, and accelerates through data retrieval, advanced visualization, and predictive analytics, with a focus on regulatory compliance and support for GMP regulations and other relevant standards, enabling pharmaceuticals to data orchestration and workflow management, and enhancing pharmaceutical knowledge.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 4
- Website
- intelligenceq.ai/
- Ownership
- Privately Held (backing)
IntelligenceQ doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IntelligenceQ shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IntelligenceQ in its N-PORT filings yet. We sweep new filings monthly.